3rd Quarter - Report

CAPITOL DECISIONS, INC. for ALKERMES

Period 3rd Quarter 2011 Filed Oct 19, 2011 Signed by Carol A. McDaid, Principal

Official filing
Firm
CAPITOL DECISIONS, INC.
Client
ALKERMES
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Public Law 110-343, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 Mental health and addiction parity. Add to #17 below: National Institute of Drug Abuse (NIDA); and Center for Substance Abuse Treatment (CSAT). Public Law 110-374, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, Regulations implementation, Mental health and addiction parity. Access and reimbursement issues regarding alcohol and opioid pharmacotherapies.

LobbyistCovered position, as disclosed
CAROL MCDAID —
HOLLY MERBAUM STRAIN —

Contacted: Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES

Alcohol and Drug Abuse ALC

Public Law 110-343, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 Mental health and addiction parity. Add to #17 below: National Institute of Drug Abuse (NIDA); and Center for Substance Abuse Treatment (CSAT). Public Law 110-374, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act, Regulations implementation, Mental health and addiction parity. Access and reimbursement issues regarding alcohol pharmacotherapies.

LobbyistCovered position, as disclosed
CAROL MCDAID —
HOLLY MERBAUM STRAIN —

Contacted: HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS); SENATE

Budget/Appropriations BUD

Issues regarding access to Pharmacotherapies for addicition: S. 1572/H.R.2596, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2012 S.1599,Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, FY2012 Add to #17 below:National Institute of Drug Abuse (NIDA)

LobbyistCovered position, as disclosed
CAROL MCDAID —
HOLLY MERBAUM STRAIN —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA)

Bills named: S. 1599 (112th), H.R. 2596 (112th), S. 1572 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.